The Technical Analyst
Select Language :
Cassava Sciences Inc [SAVA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Cassava Sciences Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Cassava Sciences Inc is listed at the  Exchange

-0.64% $20.29

America/New_York / 28 mar 2024 @ 16:00


Cassava Sciences Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 877.04 mill
EPS: -2.32
P/E: -8.75
Earnings Date: Apr 29, 2024
SharesOutstanding: 43.23 mill
Avg Daily Volume: 0.686 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Sell
DE: Sell
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/a
Gr.Profitn/an/a
Ebit
Asset
Debtn/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -8.75 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-1.49x
Company: PE -8.75 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$2.89
(-85.76%) $-17.40
Date: 2024-03-28
Expected Trading Range (DAY)

$ 19.11 - 21.47

( +/- 5.80%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-12-06 Nicaise Claude Buy 20 000 Stock Option (Right to Buy)
2023-12-06 Nicaise Claude Buy 0
2023-12-06 Gravier Pierre Buy 20 000 Stock Option (Right to Buy)
2023-12-06 Anderson Robert Eugene Jr Buy 20 000 Stock Option (Right to Buy)
2023-12-06 Gravier Pierre Buy 0
INSIDER POWER
78.87
Last 90 transactions
Buy: 1 816 102 | Sell: 547 962

Forecast: 16:00 - $20.29

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $20.29
Forecast 2: 16:00 - $20.29
Forecast 3: 16:00 - $20.29
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $20.29 (-0.64% )
Volume 0.468 mill
Avg. Vol. 0.686 mill
% of Avg. Vol 68.25 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Cassava Sciences Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Cassava Sciences Inc

RSI

Intraday RSI14 chart for Cassava Sciences Inc

Last 10 Buy & Sell Signals For SAVA

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$25.39N/AActive
Profile picture for
            Cassava Sciences Inc

SAVA

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

Last 10 Buy Signals

Date Signal @
PEPECOINUSDMar 29 - 02:245.83
VRXUSDMar 29 - 02:1960.44
^N300Mar 29 - 02:00594.52
CBKUSDMar 29 - 02:151.087
ORCAUSDMar 29 - 02:153.83
TRXUSDMar 29 - 02:10$0.120
BADGERUSDMar 29 - 02:117.11
INDEXUSDMar 29 - 02:085.97
FUMOUSDMar 29 - 02:109 998.30
FTNUSDMar 29 - 02:101.819

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.